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Abstract: Introduction: Selenomonas noxia (SN) is an important periodontal pathogen, associated
with gingivitis and periodontitis. Many studies have found associations between SN and indicators
of poor health outcomes, such as smoking, low socioeconomic status and obesity. However, less
is known about the prevalence of this organism and more specifically about other oral site-specific
locations that may harbor this organism. Methods: Using an existing patient repository (n = 47)
of DNA isolated from saliva and other oral sites (n = 235), including the dorsum of the tongue,
lower lingual incisor, upper buccal molar and gingival crevicular fluid (GCF), molecular screening
for SN was performed. Screening results were analyzed for associations between demographic
variables (age, sex, race/ethnicity) and clinical information (body mass index or BMI, presence of
orthodontic brackets, primary/mixed/permanent dentition). Results: qPCR screening revealed a
total of n = 62/235 sites or 26.3% harboring SN with saliva and GCF (either alone or in combination
with one or more sites) most often observed (Saliva, n = 23/27 or 85.18%, GCF, n = 14/27 or 51%).
Analysis of site-specific data revealed most positive results were found among saliva and GCF alone
or in combination, with fewer positive results observed among the tongue (33.3%), lower lingual
incisor (29.6%), and upper buccal molar (25.9%). No significant associations were found between
demographic or clinical variables and presence of SN at any site. Conclusions: These results may be
among the first to describe site-specific locations of S. noxia among various additional oral biofilm
sites. These data may represent a significant advancement in our understanding of the sites and
locations that harbor this organism, which may be important for our understanding of the prevalence
and distribution of these organisms among patients of different ages undergoing different types of
oral treatments, such as orthodontic treatment or therapy.
Keywords: Selenemonas noxia; periodontal; oral; saliva; screening
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Selenomonas noxia (SN) is an anaerobic, gram-negative, crescent shaped bacterium
found in the oral cavity and gastrointestinal tract of both humans and other mammalian
species [1,2]. Early studies reported that this organism aggregates with many known periodontal pathogens, including Fusobacterium nucleatum (FN) and Porphyromonas gingivalis
(PG), and is most strongly associated with the microbial profile of patients with gingival and
periodontal disease [3,4]. Molecular profiling of this organism revealed this gingival crevice
and periodontal pocket pathogen may be a leading indicator for the microbial “switch”
from normal to inflamed tissue and a potential biomarker for the onset of aggressive
gingivitis and periodontitis [4–6].
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More detailed comparative analyses of elderly and periodontal patients, as well as
those with Papillon–Lefevre syndrome (a rare form of precocious, early-onset pediatric
periodontitis) found strong associations with SN prevalence, as well as site-specific bacterial
levels within the gingival crevice and periodontal pockets [7–9]. Comprehensive analysis
of risk factors for development of gingivitis and periodontal disease, such as smoking, low
socioeconomic status and reduced access to health services and information have revealed
these factors also influence SN prevalence [10,11].
Additional factors that may influence the prevalence of SN may include the placement
of orthodontic brackets [12]. This may alter the behavioral and dietary patterns for adolescents and young adults, thereby increasing the frequency of gingivitis and prevalence
of periodontal organisms, such as FN, PG and SN [13]. In fact, the clustering of these
microbes in both supragingival and subgingival biofilms has been observed in these patient
populations [14].
More recent evidence has now suggested that SN may also be associated with other
adverse health outcomes, such as obesity [15]. One study found that 98.4% of obese women
could be identified based upon the presence of this one bacterial species (SN) in amounts
greater than 1.05% of total salivary bacteria. As this organism is capable of fermenting
“indigestible” carbohydrates and extracting additional calories from fiber-containing foods,
this may suggest that routine screening of saliva for this organism may provide significant
clinical information regarding oral and systemic health risks among dental patients in
routine care [16,17].
However, the presence of this bacteria in samples of unstimulated saliva suggests that
SN may be present not only in gingival crevices and periodontal pockets but also in other
biofilms and oral sites, such as the supragingival biofilm [18,19]. Although studies from this
group have attempted to identify patients with oral SN from unstimulated saliva, no studies
to date have evaluated the site-specific oral locations of SN within the oral cavity [20,21].
In addition, some studies have demonstrated that specific biologic determinants, such as
age and sex, may influence the presence of oral biofilms and their specific constituents,
which may provide much needed contextual and correlated information [22,23].
Based upon this information, the primary goal of this study was to determine which
specific oral sites other than the gingival crevice and saliva may harbor this organism, including the dorsum of the tongue, lingual surfaces of the mandibular incisor, and buccal surface of the maxillary molars using an existing patient repository. The secondary objectives
of this study were to determine if any of patient demographics (age, sex, race/ethnicity)
or clinical information (body mass index or BMI, permanent, primary or mixed dentition,
brackets or orthodontic appliances) were associated with these SN results.
2. Materials and Methods
2.1. Human Subjects
This retrospective study of existing DNA isolated from clinical saliva samples was
reviewed and approved exempt by the Office for the Protection of Research Subjects (OPRS)
and Institutional Review Board (IRB) at the University of Nevada, Las Vegas (UNLV)
#1717625-1 titled “Retrospective analysis of microbial prevalence from DNA isolated from
saliva samples originally obtained from the University of Nevada, Las Vegas (UNLV)
School of Dental Medicine (SDM) pediatric and clinical population”. The original study
protocol under which the saliva samples were collected was approved under protocol
OPRS#1305-4466M “The Prevalence of Oral Microbes in Saliva from the UNLV School of
Dental Medicine Pediatric and Adult Clinical Population” in 2013.
2.2. Study Protocol
This study was a retrospective study of previously collected saliva and oral samples.
In brief, in the original study sample collection protocol adult patients over 18 years of age
were asked to participate and provide Informed Consent. Pediatric patients over the age
of seven but under the age of 18 were asked to participate and provide Pediatric Assent.

Curr. Issues Mol. Biol. 2021, 43

355

In addition, a parent or guardian for each pediatric patient was also asked to provide
Informed Consent. Inclusion criteria included all patients willing to participate in the
voluntary study of microbial prevalence who provided Informed Consent or Pediatric
Assent. Exclusion criteria included all patients who declined to participate or declined
to provide Informed Consent or Pediatric Assent. No patients were excluded due to the
presence of systemic diseases or their related conditions and associated medications.
2.3. Sample Collection
In the original study collection protocol, saliva samples were collected in sterile tubes
(up to 5 mL) and were labeled with a randomly generated, non-duplicated number to
prevent any patient identifying information from being associated with any sample. In
addition, paper points were used to collect gingival crevicular fluid (GCF) from the central
maxillary incisor and biofilm samples from the dorsum of the tongue, lingual surface of
the mandibular incisors and buccal surface of the maxillary molars. All samples were
collected at the beginning of the randomly chosen clinic session, prior to any hygiene or
other clinical treatment protocol. All samples were stored on ice and transferred within
two hours to a biomedical laboratory for storage at −80 ◦ C for processing.
Finally, basic demographics (age, sex, race/ethnicity) and clinical information (body
mass index, permanent, primary or mixed dentition, brackets or orthodontic appliances)
were collected in the original protocol for subsequent analysis. Due to the nature of the
original saliva sampling study objectives, additional clinical information such as decayedmissing-filled teeth (DMFT) score, smoking status, periodontal disease and periodontal
pocket depth (PPD) scores were not collected and were therefore not available for analysis
in the current retrospective analysis.
2.4. DNA Isolation
DNA was extracted from 100 µL of each saliva sample using the phenol: chloroform
extraction method using TRIzol reagent from Invitrogen (Waltham, MS, USA). DNA was
extracted from paper points by adding 100 µL of sterile 1X phosphate buffered saline
(PBS) to each tube and vortexing the tube to release any collected materials. TRIzol
from ThermoFisher (Fair Lawn, NJ, USA) was then added to each tube (300 µL) and the
extraction method was completed according to the manufacturer protocol, as previously
described [24]. In brief, 200 µL of chloroform was added to each tube and then centrifuged
at 12,000× g (relative centrifugal force, RCF) for 15 min at 4 ◦ C. The supernatant was
removed and placed into a new micro centrifuge tube with 100 µL of isopropanol to
precipitate the DNA. Samples were then centrifuged to pellet the DNA, which was then
washed with ethanol prior to resuspension in 100 µL of sterile, nuclease-free water.
2.5. DNA Screening
DNA isolates were screened using a NanoDrop spectrophotometer from ThermoFisher
(Fair Lawn, NJ, USA) at absorbances of A260 nm and A280 nm to determine the quality
and quantity. Absorbance readings at A260 were used to determine the quantity, adjusting
for the dilution factor. A minimum of 10 ng was required for each sample to be included in
the current study. The ratio of absorbance readings at A260:A280 were used to determine
the sample quality, with minimum sample ratios set at the ratio of 1.7.
2.6. qPCR (Quantitative Polymerase Chain Reaction)
Each sample with sufficient DNA concentration (10 ng) and sufficient quality
(A260:A280 > 1.7) was then identified for inclusion in this study. Screening for the presence
of microbial DNA was performed using primers specific to this organism, Selenomonas noxia
(SN), as previously described [16,20,21]. In brief, qPCR was performed using ABsolute
SYBR green (no ROX) from ThermoFisher (Fair Lawn, NJ, USA). Each reaction consisted of
12.5 µL of 2X ABsolute SYBR green master mix, 1.75 µL of forward primer, 1.75 of reverse
primer, 1.5 µL of sample (diluted to 1.0 ng/µL) and 7.5 µL of distilled, nuclease-free water.
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Each reaction was performed using enzyme activation for 15 min at 95 ◦ C followed by
40 cycles of denaturation for 15 s at 95 ◦ C, annealing at the primer specific temperature of
each primer pair for 30 s and extension at 72 ◦ C for 30 s.
Positive Control 16S rRNA Universal Primer
Forward 16S rRNA universal primer, 50 -ACG CGT CGA CAG AGT TTG ATC CTG
GCT-30
27 nt, 56% GC, Tm 76 ◦ C
Reverse 16S rRNA universal primer, 50 -GGG ACT CAG TAT TAT-30
21 nt, 48% GC, Tm 62 ◦ C
Annealing temperature for primer set: 57 ◦ C
2.7. Selenomonas noxia (SN) Primer
Forward primer- SN-F1, 50 -TCT GGG CTA CAC ACGT ACT ACA ATG-30
25 nt, 48% GC, Tm: 68 ◦ C
Reverse primer- SN-R1, 50 -GCC TGC AAT CCG AAC TGA GA-30
20 nt, 55% GC, Tm: 68 ◦ C
Annealing temperature for primer set: 63 ◦ C
2.8. Statistical Analysis
Descriptive statistics were compiled for all demographic variables (age, sex, race/ethnicity)
and comparisons were made with the overall clinic demographics using Chi square analysis from GraphPad (San Diego, CA, USA). DNA concentration and other parametric
measurements were compiled and descriptive statistics provided. Analysis of these data
was performed using analysis of variance (ANOVA) using Microsoft Excel (Redmond,
WA, USA).
3. Results
A total of N = 47 patient samples were available from the existing repository for
analysis and screening in the current study (Table 1). In brief, the sample demographics
revealed slightly less than half of samples were derived from females (42.6%), which was
not significantly different from the overall demographics of the pediatric clinic from which
the samples were originally taken (p = 0.2300). The racial and ethnic breakdown of the
study sample was mostly derived from minority (non-White) patients (83%), which was
significantly higher than the overall percentage within the clinic (65.4%) (p = 0.0002).
Table 1. Study sample demographics.
Study Sample

Pediatric Clinic

Statistical Analysis

Female

42.6% (n = 20/47)

49.1%

χ2 = 1.441, d.f. = 1

Male

57.4% (n = 27/47)

50.9%

p = 0.2300

Sex

Race/Ethnicity
White

17.0% (n = 8/47)

34.6%

χ2 = 14.242, d.f. = 1

Minority (non-White)

83.0% (n = 39/47)

65.4%

p = 0.0002

Hispanic

63.8% (n = 30/47)

58.6%

Black/Asian/Other

19.2% (n = 9/47)

16.8%

Average

10.26 years

10.41 years

Range

7–15 years

0–17 years

Age
p = 0.781

DNA isolated from each of the five sites from each patient sample was analyzed
for purity and concentration (Figure 1). More specifically, data were organized to create
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In order to verify the presence of bacterial DNA from each sample, real time quantitative polymerase chain reaction (RT-qPCR) was performed using 16S rRNA (Figure 2).
These data demonstrated that all samples harbored DNA of sufficient quantity and quality
for this analysis. The cycle threshold (CT) average count for the study samples was significantly higher (CT range: 28.2–30.1) than the average CT count for the known bacterial
standards at 10 ng/µL, 5 ng/µL, and 2 ng/µL (CT average 12.86) (p = 0.00018), but not
significantly different from one another (p = 0.513).
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Table 2. Negative binomial regression analysis of study results.
Table 2. Negative binomial regression analysis of study results.

DNA conc.
conc.
DNA
DNA
purity
DNA purity
Age
Age
BMI
BMI
Sex
Sex
Ethnicity
Ethnicity
Dentition
Dentition
Brackets
Brackets

Saliva
Saliva
Pr(>|z|)
Pr(>ǀzǀ)

GCF
GCF
Pr(>|z|)
Pr(>ǀzǀ)

0.499
pp==0.499
p
=
0.619
p = 0.619
0.943
pp==0.943
p
=
0.749
p = 0.749
0.525
pp==0.525
p
=
0.554
p = 0.554
0.675
pp==0.675
0.975
pp==0.975

0.816
pp==0.816
p
=
0.980
p = 0.980
0.639
pp==0.639
p
=
0.967
p = 0.967
0.414
pp==0.414
p
=
0.447
p = 0.447
0.826
pp==0.826
0.858
pp==0.858

Dorsal
Dorsal
Tongue
Tongue
Pr(>|z|)
Pr(>ǀzǀ)
0.862
pp== 0.862
p
=
0.983
p = 0.983
0.991
pp== 0.991
p
=
0.725
p = 0.725
0.103
pp== 0.103
p
=
0.082
p = 0.082
0.228
pp== 0.228
0.145
pp== 0.145

Lower Lin‐ Upper Buc‐ Number of
Lower
Upper
Number of
gual
cal
sites
Lingual
Buccal
Sites
Pr(>|z|)
Pr(>|z|)
Pr(>|z|)
Pr(>ǀzǀ)
Pr(>ǀzǀ)
Pr(>ǀzǀ)
0.476
0.225
0.313
pp== 0.476
pp== 0.225
pp== 0.313
p
=
0.382
p
=
0.591
p
=
0.923
p = 0.382
p = 0.591
p = 0.923
0.638
0.082
0.181
pp== 0.638
pp== 0.082
pp== 0.181
p
=
0.406
p
=
0.633
p
=
0.595
p = 0.406
p = 0.633
p = 0.595
0.290
0.747
0.317
pp== 0.290
pp== 0.747
pp== 0.317
p
=
0.599
p
=
0.783
p
=
0.843
p = 0.599
p = 0.783
p = 0.843
0.220
0.169
0.331
pp== 0.220
pp== 0.169
pp== 0.331
0.656
0.939
0.825
pp== 0.656
pp== 0.939
pp== 0.825

4. Discussion
The overall objective of this study was to determine which oral sites may harbor
S. noxia, including saliva and the gingival crevice, but also additional sites, such as the
dorsum of the tongue, lingual surfaces of the mandibular incisor, and buccal surface of
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the maxillary molars. The results of this study were successful in demonstrating that this
organism may be detectable most often from samples of unstimulated saliva, comparable
to findings reported from other studies [25,26]. These results also support previous reports
from this group regarding the oral prevalence of this organism, based upon molecular
screening of salivary samples [20,21]. In addition, these results demonstrating the presence
of this organism in GCF (either alone or in combination with saliva) also support additional
studies that have demonstrated the presence of this organism in significant percentages of
GCF samples [4–6,27].
However, the results of this study also demonstrated that S. noxia may be present in a
number of additional oral sites, such as the dorsum of the lingual surfaces of the mandibular
incisor, and buccal surface of the maxillary molars, even if the GCF tested negative for
this periodontal pathogen. Based upon these results, this may be the first description of the
presence of this organism among additional oral sites, suggesting the presence of this organism
at these specific biofilm locations may be more commonplace than previously though and
may be similar to other studies of gram-negative periodontal pathogens that aggregate in
developing or existing biofilms on teeth and the tongue [28–30]. In fact, recent studies have
postulated that enrichment of periodontal pathogens may first occur in developing biofilm
prior to the development of subgingival inflammation, gingivitis or periodontal disease–
suggesting more detailed analysis of these oral sites may be needed in future studies [31–33].
These results also revealed no significant associations between clinical variables that
were previously observed, such as increased prevalence in the presence of orthodontic
brackets [12–14] and associations with higher BMI [15–17]. The lack of significant associations between these clinical variables and the presence of S. noxia may be due to the
overall sample size of this pilot study. Most models for analyzing mixed predictor variables with clustered outcome data suggest a minimal sample size of at least n = 20 per
group (sex, race/ethnicity) or category (primary, mixed, permanent dentition), which was
mostly reached but not significantly exceeded in most variables and categories within
this study [34–36]. In addition, the lack of clinical information regarding oral health and
the presence of oral disease, including periodontal disease and the associated periodontal
pocket depth or PPD information, may limited the inferences that can be made from this
study. In future studies, an increase in overall sample size to accommodate at least n = 50
per group or category may be needed to more accurately evaluate any potential associations
between variables and molecular screening outcomes, as well as the inclusion of additional
oral health parameters, such as DMFT and PPD scores and the presence or absence of oral
and systemic diseases and their corresponding medications and treatments.
The clinical and diagnostic implications of this study may provide further evidence
for significance as the proximity of some of these locations (e.g., buccal surface of maxillary
molars) may be associated with complications and infections of other oral sites, including
the parotid gland and lymph nodes [37,38]. Although other well-defined diagnostic methods exist to sample these sites, this study provides an additional screening and diagnostic
tool to complement the array of methods used to locate, identify and quantify these oral
pathogens [39,40]. This type of information is useful as the extent and composition of oral
biofilm sites and the relationships and interconnections with extraoral infections becomes
more replete, the decisions and choices regarding treatment and interventions (including
surgical modalities) may differ and outcomes may vary based upon this information in
order to fully restore bone volume or tissue function [41–43].
In addition, as many types of systemic infections, including conditions involving
immunocompromised patients (e.g., HIV or COVID-19) involve complications from oral
bacteria that can colonize and translocate endotracheal intubation tubes, the ability to
sample and specifically locate biofilm constituents based upon location, such as the dorsum
of the tongue becomes critically important [44–47]. In fact, many other clinical settings
currently provide oral sampling for other systemic conditions that include, but are not
limited to, HIV and hepatitis C viruses [48–51].
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Additional clinical applications may include the role and relationship of oral biofilms
and site specific locations with the accuracy, measurements and subsequent success of
intra-oral scanners and other methods employed in the field of digital dentistry [52–54].
Evidence has suggested a strong relationship between oral hygiene, biofilm accumulation
and failure of many types of clinical procedures, including implants [55–57]. Based upon
these studies, it becomes clear that a more detailed and thorough analysis of oral biofilm
sites and their constituents may be critically important to ensure the success (and prevent
the failure of) many other types of clinical dental treatments, as well as the outcomes of
other types of respiratory and systemic infections [58,59].
However, the most significant and important clinical associations of SN remain the
relationships between this organism and the presence or development of periodontal
disease [60,61]. The relationship between SN and the aggressiveness of associated periodontal disease suggests that treatment protocols and clinical interventions may benefit
from molecular screening to indicate the presence or levels of SN to ensure appropriate
methods are used for effective treatment [62,63]. In fact, other oral and systemic conditions
including oral cancer and stomatitis have been associated with periodontal disease development and progression, although the relationships with SN more specifically have yet
to be evaluated [64,65]. The exploration of these relationships is of critical importance as
new evidence continues to emerge that demonstrates the potential relationship between
existing illness, such as oral cancer and periodontal disease, may influence both risk and
progression of newly emerging pathogens, such as SARS-CoV-2 (COVID-19) [66,67].
5. Conclusions
Despite the limitations of the current pilot study, these results may be among the first
to describe site-specific locations of S. noxia among various oral biofilm sites. These data
may represent a significant advancement in our understanding of the sites and locations
that harbor this organism, which may be important for our understanding of the prevalence
and distribution of these organisms among patients of different ages undergoing different
types of oral treatments, such as orthodontics.
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